Company Profile
LEMON Biotechnology
Guangzhou Lemon Biotechnology Co., Ltd. (hereinafter referred to as "Lemon Biotech") is an innovative technology enterprise that utilizes "neck-breaking" biotechnology to transform scientific achievements into practical applications. With an industrial mindset, we drive the development of modern agriculture by turning citrus residues into valuable resources. Our focus lies in producing high-quality pectin and citrus fiber.
Under our company, we have three national-level high-tech enterprises and three provincial-level specialized and innovative enterprises. Our main product, pectin, is widely used in the domestic dairy, beverage, jam, confectionery, and pharmaceutical industries, contributing to the overall health and wellness sector. We have successfully broken the monopoly of foreign giants in the Chinese market, becoming the only Chinese-owned pectin company with core technologies spanning the entire industry chain. Moreover, we have expanded our presence to mature markets in Europe and America.
In 2023, Lemon Biotech was recognized as a future unicorn innovation enterprise in Guangzhou, a leading agricultural enterprise in the city, one of the top 50 leading companies preparing for IPO, and one of Guangzhou's top 10 most promising growth enterprises. We also received accolades such as Deloitte's "China Pharmaceutical and Healthcare Star of Tomorrow." Our goal is to become one of the top three global players in the deep processing of the entire citrus industry chain within the next three years.
Lemon Biotech has established research and development platforms in collaboration with South China University of Technology and South China Normal University. Currently, our company has seven doctoral degree holders in engineering and dozens of master's degree holders. With a well-established research and development management system and excellent working environment, we have cultivated a highly experienced R&D team dedicated to providing comprehensive solutions to our customers.
Lemon Biotech operates five production
bases strategically located in different regions.
The Lemon Biotech production base in Jiangxi covers an area of over 140 acres and currently has an annual production capacity of 3,000 tons of pectin, 1,500 tons of citrus fiber, and 1,200 tons of refined carrageenan.
The Nanzomai Biological facility in Fuzhou has the capability to produce 50,000 kilograms of high-purity mogroside extract from monk fruit annually.
The Lemon Biotech production base in Puyang covers an area of 60 acres and specializes in the production of food-grade pectin additives, which are used in dairy products, soft candies, fruit jams, and other food applications.
The Zhangzhou Lvxing Marine Biotechnology company focuses on the application research and sales of hydrocolloids such as carrageenan and agar, and is also involved in the import and export of bulk seaweed products.
The Lemon Biotech facility in Huaiji is a planned project with a total investment of 1.018 billion RMB. It will cover an area of 200 acres and is expected to generate an annual output value of 1.75 billion RMB and contribute 70 million RMB in tax revenue once it reaches full production capacity.